Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic.

Astrocyte COVID-19 Neuroinflammation Neuropsychiatric disorders Reactive gliosis SARS-CoV-2

Journal

Neurochemical research
ISSN: 1573-6903
Titre abrégé: Neurochem Res
Pays: United States
ID NLM: 7613461

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 01 07 2022
accepted: 22 07 2022
revised: 01 07 2022
pubmed: 4 8 2022
medline: 24 3 2023
entrez: 3 8 2022
Statut: ppublish

Résumé

COVID-19, initially regarded as specific lung disease, exhibits an extremely broad spectrum of symptoms. Extrapulmonary manifestations of the disease also include important neuropsychiatric symptoms with atypical characteristics. Are these disturbances linked to stress accompanying every systemic infection, or are due to specific neurobiological changes associated with COVID-19? Evidence accumulated so far indicates that the pathophysiology of COVID-19 is characterized by systemic inflammation, hypoxia resulting from respiratory failure, and neuroinflammation (either due to viral neurotropism or in response to cytokine storm), all affecting the brain. It is reasonable to hypothesize that all these events may initiate or worsen psychiatric and cognitive disorders. Damage to the brain triggers a specific type of reactive response mounted by neuroglia cells, in particular by astrocytes which are the homeostatic cell par excellence. Astrocytes undergo complex morphological, biochemical, and functional remodeling aimed at mobilizing the regenerative potential of the central nervous system. If the brain is not directly damaged, resolution of systemic pathology usually results in restoration of the physiological homeostatic status of neuroglial cells. The completeness and dynamics of this process in pathological conditions remain largely unknown. In a subset of patients, glial cells could fail to recover after infection thus promoting the onset and progression of COVID-19-related neuropsychiatric diseases. There is evidence from post-mortem examinations of the brains of COVID-19 patients of alterations in both astrocytes and microglia. In conclusion, COVID-19 activates a huge reactive response of glial cells, that physiologically act as the main controller of the inflammatory, protective and regenerative events. However, in some patients the restoration of glial physiological state does not occur, thus compromising glial function and ultimately resulting in homeostatic failure underlying a set of specific neuropsychiatric symptoms related to COVID-19.

Identifiants

pubmed: 35922744
doi: 10.1007/s11064-022-03709-7
pii: 10.1007/s11064-022-03709-7
pmc: PMC9362636
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1015-1025

Informations de copyright

© 2022. The Author(s).

Références

Mol Cell Neurosci. 2004 Nov;27(3):296-305
pubmed: 15519244
Crit Care. 2019 Nov 12;23(1):352
pubmed: 31718695
Neurochem Res. 2015 Feb;40(2):389-401
pubmed: 25113122
J Psychiatr Res. 2022 May;149:114-123
pubmed: 35272208
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
Emerg Infect Dis. 2004 Feb;10(2):342-4
pubmed: 15030709
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20130595
pubmed: 25225089
Neurosci Lett. 2019 Jan 10;689:56-62
pubmed: 30096375
Acta Neuropathol. 2020 Jul;140(1):1-6
pubmed: 32449057
Transl Psychiatry. 2022 May 17;12(1):205
pubmed: 35581186
Neurosci Biobehav Rev. 2014 Jan;38:160-72
pubmed: 24300694
Trends Immunol. 2001 Feb;22(2):83-7
pubmed: 11286708
J Neurol Sci. 2022 Mar 15;434:120162
pubmed: 35121209
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2200960119
pubmed: 35951647
Fluids Barriers CNS. 2022 Jun 7;19(1):46
pubmed: 35672716
Cold Spring Harb Perspect Biol. 2015 Jun 22;8(1):a020479
pubmed: 26101081
J Thorac Dis. 2020 Oct;12(Suppl 2):S163-S175
pubmed: 33214921
Brain Res Rev. 2007 Nov;56(1):119-47
pubmed: 17659349
Cell Tissue Res. 2022 Mar;387(3):337-350
pubmed: 34164732
Physiol Rev. 2018 Jan 1;98(1):239-389
pubmed: 29351512
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
PLoS One. 2009 May 28;4(5):e5709
pubmed: 19479051
ASN Neuro. 2012 May 01;4(4):201-5
pubmed: 22455879
Biomolecules. 2021 Apr 19;11(4):
pubmed: 33921556
Front Cell Neurosci. 2015 Feb 02;9:28
pubmed: 25698933
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Neurology. 2020 Sep 22;95(12):e1754-e1759
pubmed: 32546655
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119
pubmed: 35858406
Science. 2015 Mar 6;347(6226):1138-42
pubmed: 25700174
Cold Spring Harb Perspect Biol. 2015 Aug 20;8(2):a020453
pubmed: 26492571
Neurology. 2020 Aug 4;95(5):224-225
pubmed: 32444492
Front Cell Neurosci. 2021 Apr 09;15:662578
pubmed: 33897376
Cell. 2020 Oct 1;183(1):16-27.e1
pubmed: 32882182
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
Neurochem Res. 2021 Oct;46(10):2538-2550
pubmed: 33961207
Trends Mol Med. 2018 Nov;24(11):950-962
pubmed: 30314877
Biochim Biophys Acta. 2016 Mar;1862(3):483-91
pubmed: 26655603
JAMA. 2020 May 26;323(20):2089-2090
pubmed: 32320008
J Clin Sleep Med. 2021 Feb 1;17(2):299-313
pubmed: 33108269
JAMA Neurol. 2020 Aug 1;77(8):1028-1029
pubmed: 32469400
Front Cell Neurosci. 2018 Oct 26;12:386
pubmed: 30416428
Front Immunol. 2020 Jun 26;11:1626
pubmed: 32714336
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
J Neurol Sci. 2020 Jun 15;413:116832
pubmed: 32299017
J Neurochem. 2016 Jul;138(1):74-85
pubmed: 27085714
J Neurol. 2020 Aug;267(8):2179-2184
pubmed: 32458193
Curr Hypertens Rep. 2010 Jun;12(3):170-5
pubmed: 20424953
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Biomedicines. 2022 Apr 20;10(5):
pubmed: 35625690
Glia. 2008 Jul;56(9):975-89
pubmed: 18383346
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942
pubmed: 32301997
Neurology. 2020 Sep 8;95(10):445-449
pubmed: 32586897
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Clin Infect Dis. 2005 Oct 15;41(8):1089-96
pubmed: 16163626
EMBO J. 2016 Feb 1;35(3):239-57
pubmed: 26758544
Neurology. 2020 Oct 6;95(14):e2016-e2027
pubmed: 32546654
JAMA Psychiatry. 2021 Jun 1;78(6):682-683
pubmed: 33769431
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
J Infect Dis. 2016 Mar 1;213(5):712-22
pubmed: 26486634
Aging Cell. 2009 Apr;8(2):201-13
pubmed: 19338498
JAMA Netw Open. 2021 May 3;4(5):e2112131
pubmed: 33974053
Methods Mol Biol. 2019;2034:3-11
pubmed: 31392673
J Med Virol. 2020 Jul;92(7):699-702
pubmed: 32314810
Neuron. 2017 Sep 27;96(1):17-42
pubmed: 28957666
J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47
pubmed: 19768553
J Rehabil Med. 2020 May 25;52(5):jrm00063
pubmed: 32449782
Annu Rev Immunol. 2014;32:367-402
pubmed: 24471431
J Immunol. 2011 Jun 15;186(12):6771-8
pubmed: 21562161
Eur J Pharmacol. 2020 Apr 5;872:172950
pubmed: 31987711
Brain Behav Immun. 2022 Mar;101:93-135
pubmed: 34973396
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
Transl Psychiatry. 2020 Jul 30;10(1):261
pubmed: 32732883
Life Sci. 2020 Dec 1;262:118568
pubmed: 33035589
Nat Med. 2022 Jul;28(7):1461-1467
pubmed: 35614233
Physiol Rev. 2011 Apr;91(2):461-553
pubmed: 21527731
Brain Commun. 2020 Nov 23;2(2):fcaa205
pubmed: 33376990
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
JAMA Psychiatry. 2017 Aug 1;74(8):833-840
pubmed: 28636705
Physiol Rev. 2019 Jan 1;99(1):21-78
pubmed: 30280653
J Biol Chem. 2003 Apr 11;278(15):13512-9
pubmed: 12551932
Adv Exp Med Biol. 2019;1175:117-128
pubmed: 31583586
Int J Infect Dis. 2016 Aug;49:129-33
pubmed: 27352628
Acta Physiol (Oxf). 2021 Oct;233(2):e13717
pubmed: 34264006
Front Cell Neurosci. 2021 Nov 29;15:748136
pubmed: 34912192
Brain Behav Immun. 2021 Mar;93:415-419
pubmed: 33359380
Curr HIV Res. 2012 Jul;10(5):392-406
pubmed: 22591363
Cell Mol Neurobiol. 2021 Jan;41(1):1-15
pubmed: 32285247
Nat Rev Microbiol. 2006 Feb;4(2):121-32
pubmed: 16415928
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Front Cell Neurosci. 2020 Nov 11;14:592214
pubmed: 33304243
Brain Sci. 2022 Apr 30;12(5):
pubmed: 35624973
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
Prog Neurobiol. 2021 Jul;202:102052
pubmed: 33894330
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
J Neurol. 2022 Jan;269(1):44-46
pubmed: 34143277
Adv Exp Med Biol. 2016;949:27-45
pubmed: 27714683
Ann Intern Med. 2021 Sep;174(9):1252-1260
pubmed: 34224254
Ann N Y Acad Sci. 2021 Feb;1486(1):90-111
pubmed: 33009668
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
Int J Mol Sci. 2021 Mar 06;22(5):
pubmed: 33800954
J Infect. 2021 Oct;83(4):496-522
pubmed: 34192525
Annu Rev Immunol. 2019 Apr 26;37:73-95
pubmed: 31026414
Cold Spring Harb Perspect Biol. 2014 Nov 07;7(2):a020420
pubmed: 25380660
Neurosci Biobehav Rev. 2022 Jan;132:1086-1098
pubmed: 34740755
Brain Behav Immun. 2020 Jul;87:149
pubmed: 32387508
Sci Adv. 2020 Jul 31;6(31):
pubmed: 32937591
Exp Mol Pathol. 2020 Aug;115:104474
pubmed: 32454103
Brain Pathol. 2017 Sep;27(5):629-644
pubmed: 28805002
Brain Neurosci Adv. 2018 Dec 4;2:2398212818817495
pubmed: 32166166
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
Pathog Dis. 2020 Jun 1;78(4):
pubmed: 32633327
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
PLoS Pathog. 2021 Feb 17;17(2):e1009225
pubmed: 33596266
J Microbiol Immunol Infect. 2021 Feb;54(1):93-96
pubmed: 32576457
Transl Psychiatry. 2022 Jan 10;12(1):5
pubmed: 35013105
JAMA Netw Open. 2020 Jul 1;3(7):e2014053
pubmed: 32609353
CMAJ. 2021 Apr 19;193(16):E540-E548
pubmed: 33741725
Nat Neurosci. 2014 Mar;17(3):400-6
pubmed: 24487234
Life Sci. 2020 Sep 15;257:118054
pubmed: 32663575
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Front Pharmacol. 2020 Jan 29;10:1656
pubmed: 32063858
Mol Psychiatry. 2021 Sep;26(9):4982-4998
pubmed: 33542468
IUBMB Life. 2013 Dec;65(12):957-61
pubmed: 24376207
Lancet Public Health. 2022 May;7(5):e406-e416
pubmed: 35298894
Science. 2020 Apr 24;368(6489):356-360
pubmed: 32327580
Acta Physiol (Oxf). 2020 Jul;229(3):e13473
pubmed: 32223077
Neurosci Behav Physiol. 2022;52(3):319-325
pubmed: 35692961
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7117-7122
pubmed: 29915057
Neuron. 2015 Apr 22;86(2):374-86
pubmed: 25905811
Cell Death Differ. 2020 May;27(5):1451-1454
pubmed: 32205856
Mol Psychiatry. 2023 Jan;28(1):423-433
pubmed: 35668159
Asian J Psychiatr. 2022 Jun;72:103097
pubmed: 35405524

Auteurs

Luca Steardo (L)

Psychiatric Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Luca Steardo (L)

Department of Physiology and Pharmacology "Vittorio Erspamer", SAPIENZA University of Rome, Rome, Italy.
Università Giustino Fortunato, Benevento, Italy.

Caterina Scuderi (C)

Department of Physiology and Pharmacology "Vittorio Erspamer", SAPIENZA University of Rome, Rome, Italy. caterina.scuderi@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH